Corticosteroids are beneficial as treatment of certain tuberculosis syndromes. We reviewed all cases of peritoneal tuberculosis diagnosed at our institution over 10 years to evaluate the role of corticosteroid administration combined with antituberculous therapy. Nine patients were treated with steroids plus antituberculosis agents (cases), and 26 received antituberculosis treatment only (controls). The two groups were not significantly different in terms of their basic demographics or disease. Nineteen controls compared with one case had recurrent abdominal pain. Seven controls had 17 emergency department visits because of abdominal pain. Intestinal obstruction was diagnosed for five of these patients, four of whom underwent laparotomy revealing extensive adhesions. Three controls died, and no case died. No case required laparotomy, had a diagnosis of intestinal obstruction, or visited the emergency department because of abdominal pain. These findings suggest that corticosteroid administration combined with antituberculosis treatment reduces the frequency of morbidity and complications in patients with peritoneal tuberculosis.
The recent resurgence of tuberculosis (TB) is global. This lished. Some studies showed beneficial effects, but others did not [16, 17] . Considering the limited data [16] and extrapolating increase has been mainly attributed to HIV infection, but TB also affects the HIV-negative population to a lesser extent [1] .
from the benefit of steroid treatment for other TB conditions [4 -12] , some of the physicians at our institution routinely The increase in the incidence of extrapulmonary TB over a 5-year period was 20%, compared with an incidence of pulmoadminister steroids along with antituberculous therapy to patients with peritoneal TB. We reviewed our experience with nary tuberculosis of 3% in the United States [2] . Peritoneal TB accounts for 3.3% of cases of extrapulmonary TB [3] . Most corticosteroid administration combined with antituberculous therapy for peritoneal TB; the outcome for these patients was patients with TB do well with antimycobacterial therapy alone. The beneficial role of steroid administration in conjunction with also reviewed. antituberculous chemotherapy was noted for few conditions, notably pericarditis and meningitis [4 -12] . Other conditions for which steroid administration may be beneficial are severe Methods debilitation, hypoxia in association with miliary TB, and pleuWe reviewed all cases of TB at King Faisal Specialist Hospirisy [13 -15] .
tal and Research Centre (Riyadh, Saudi Arabia) over a 10-year period (1987 -1996) . Peritoneal TB was defined by at least See editorial response by Haas on pages 57 -8.
one of the following two criteria: isolation of Mycobacterium tuberculosis from ascitic fluid or a peritoneal tissue biopsy Few reports regarding the effect of steroid use in conjunction specimen, or observation of small tubercles in the peritoneum with antituberculous therapy for peritoneal TB have been pubduring laparoscopy or laparotomy with biopsy-proven granulomata and a favorable clinical response to antituberculous chemotherapy. Basic demographic and diagnostic data were collected for all the patients meeting the inclusion criteria. Data bias. If the patient complained of unexplained abdominal pain controls. These four patients were included in the analysis on the basis of their laparoscopic and histopathologic findings and during at least three different follow-up visits, recurrent abdominal pain was noted as a late complication of peritoneal TB.
their good clinical response to anti-TB medications. There was no significant difference between the patients for whom culAny emergency department visit because of abdominal pain during or after treatment was recorded, as was intestinal obtures yielded M. tuberculosis and those for whom cultures did not, in terms of their basic demographic data, duration of struction (which was indicated in the patient's record if supported by radiological evidence of air-fluid levels).
symptoms, and results of ascitic fluid analysis. M. tuberculosis was isolated from a mesenteric lymph node specimen from one The patients were grouped into two groups: those treated with steroids plus anti-TB therapy (cases) and those treated case, and two cases had chest roentgenograms suggestive of TB. M. tuberculosis was isolated from cecum, adrenal gland, with anti-TB therapy without steroids (controls). The two groups were compared in terms of their basic demographics, and liver specimens from three controls, and seven controls had chest roentgenograms suggestive of TB. symptoms and signs, duration of symptoms before treatment, diagnostic findings, susceptibility of M. tuberculosis isolates, All patients received isoniazid and rifampin at the initiation of therapy except for one control who received rifampin withtypes and duration of treatment, and follow-up findings.
Data entry and analysis were performed by Epi-Info Version out isoniazid because of concerns that this patient's chronic viral hepatitis would worsen. Use of other first-line antitubercu-6.04 (USD, Stone Mountain, GA) and Statistica Version 5.0 (StatSoft, Tulsa, OK). The Student's t test was used to calculate lous drugs was similar in both groups. Cases were given steroids with antituberculous therapy according to the caring phycontinuous variables, and the x 2 or Fisher's exact test was used to calculate categorical variables. A P value of õ.05 was sician's practice. Cases received a dose of prednisone, 0.5 -1.0 mg/(kgrd) for a mean of 6.6 weeks (range, 4 -9 weeks). considered significant.
Corticosteroids were given as oral prednisone once daily, and the dose was tapered by 5 -10 mg every 10 -14 days. Steroids Results were given at the initiation of anti-TB therapy to six cases and after 3, 4, and 6 days to three cases. Forty-one cases met one or both of the inclusion criteria. Six cases could not be included in the analysis: two had a
The side effects attributed to steroids in the cases' records were limited to epigastric discomfort in two cases; the discompostmortem diagnosis (M. tuberculosis was isolated from ascitic fluid that was drawn during evaluation; these cases never fort was treated by antacids in one and ranitidine in the other. A third case's oral hypoglycemic requirements were increased received anti-TB treatment), and four were referred to our institution for laparoscopy and were sent back to their referring because of either steroid or rifampin administration. All noted that side effects abated after the completion of the steroid hospitals after the procedure (peritoneal TB was confirmed by culture weeks later; no treatment was initiated at our institution, course.
There was no significant difference between the cases and and no follow-up was performed).
Detailed data were available for 35 patients. Nine were controls in terms of their mean age, gender distribution, mean duration of symptoms before treatment, duration of treatment, treated with steroids and anti-TB therapy (cases), and 26 were treated with anti-TB therapy without steroids (controls). The mean highest recorded temperature, results of ascitic fluid analysis, differential blood cell count, types and duration of anti-TB cases of peritoneal TB in both groups were spread evenly over the 10-year period. There were 17 males and 18 females. All therapy, duration of follow-up, and susceptibility pattern of the isolated organism. These findings are summarized in table 1. 35 patients were followed up for a mean of 24 months (range, 2 -118 months). The cases had a mean follow-up of 23 months During follow-up, 19 controls (73%) complained repeatedly of abdominal pain compared with one case (11%) (Fisher's (range, 13 -32 months; median, 22 months) compared with a mean follow-up of 24 months (range, 2 -118 months; median, exact test, P Å .0019). Seven controls (27%) had recurrent vomiting compared with none of the cases. These seven con-16 months) for the controls. The shorter minimal follow-up for the controls resulted from the early death of a patient in this trols presented to the emergency department 17 times because of abdominal pain and vomiting. Five of these controls were group.
Ascitic fluid specimens from 27 patients were sent for culture admitted, and intestinal obstruction with radiological evidence of air-fluid levels was diagnosed; four required laparotomy. for acid-fast bacilli (AFB); M. tuberculosis was isolated from 14 (52%) of these patients. Peritoneal biopsy specimens from Extensive adhesions were noted and thought to be the cause of the intestinal obstruction. On the other hand, no case underwent 26 patients were sent for AFB culture; M. tuberculosis was isolated from 24 (92%) of these patients. AFB staining of laparotomy or had a diagnosis of intestinal obstruction. None of the cases visited the emergency department because of abthe two culture-negative biopsy specimens was negative, and histopathologic examination of these specimens revealed casedominal pain. These data are summarized in streptomycin. The prednisone dose was tapered over the fourth month to zero. There was no difference between the two groups in terms of the initial symptomatic response. During followup, the patients treated with the steroid plus anti-TB therapy peritoneal complications compared with patients without comhad no intestinal obstruction compared with three of the 24 plications showed no significant difference in terms of their patients treated with anti-TB therapy only who had intestinal initial demographics or disease criteria. The duration of sympobstruction requiring surgical intervention to free adhesive toms before therapy for patients with complications was 8
bands. There were no deaths in either groups. To our knowlweeks longer than that for patients without (mean, 18 weeks edge, no other study in the English-language literature reported vs. 10 weeks) but was not statistically significant (P Å .17), the effect of steroids on the outcome of peritoneal TB. probably because of the small numbers.
In three recent reviews of steroid use in TB cases [13, 24, Three controls died. One of them died after 9 months of 25], peritoneal TB was not even discussed as a TB condition treatment, of complications of hepatic cirrhosis and gastrointestinal bleeding related to hepatitis C virus infection. The other two controls died after 8 and 10 weeks of treatment, respectively, of complications related to intestinal obstruction, perfo- In our series, the three deaths of controls cannot be attributed to the lack of steroid use. One patient's death was related to reported using steroids as therapy for more than one-half of their patients with tuberculous peritonitis but did not mention hepatic cirrhosis and gastrointestinal bleeding complicating viral hepatitis after several months of anti-TB treatment. The two the effect of this treatment on the patients' outcomes. Other studies of peritoneal TB retrospectively analyzed the role of other patients died of complications of peritoneal TB that may not have been prevented by steroid treatment. adding corticosteroid therapy to anti-TB treatment [27]; of 22 patients, six were given varying doses of prednisone at different Although our study was not prospective, we tried to reduce reviewer bias by first collecting follow-up data and then collecttimes in their disease course. No additional benefit was noted from steroid treatment. The outcome parameters that Piéron et ing treatment data (including steroid use) by another investigator. A prospective, randomized, double-blind study would be al. [20] evaluated were different from those in our series. In another French report [28] of 20 patients, six received steroid the investigation to convincingly prove that steroid use reduces morbidity in cases of peritoneal TB. To our knowledge, similar therapy and had more rapid resolution of symptoms than did other patients, but long-term follow-up was not reported. The studies have never been performed for other conditions (e.g., tuberculous meningitis); nevertheless, the role of steroids as case definition in these and other series [17] was not clear, and cases of abdominal or intestinal TB were also included.
adjuvant therapy for tuberculous meningitis is not disputed now. Until results of a prospective, randomized, double-blind Bennani et al. [17] prospectively randomized 50 of 100 patients to receive 30 mg of prednisone for the first 8 weeks.
trial are available, we advocate the use of steroids with anti-TB drugs to reduce the frequency of complications and morbidResponse to treatment was similar in the two groups. Followup laparoscopy after 12 or 24 months of therapy showed that ity in patients with peritoneal TB. 25 of 30 patients in the control group compared with 24 of 28 patients in the steroid group had persistent adhesions. The of the obstruction. These adhesions were attributed to previous 9. Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA. Dexamethasone peritoneal TB and the associated inflammatory fibrotic process. 
